PEL at a Buy level
Gaining momentum with an improved fundamentals plus tailwind in the Finance, holding company of a Pharma stock
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.